These data indicate that radiation promotes cetuximab-mediated ADCC and this may result in part from a novel effect of radiation enhancing the susceptibility of tumor cells to NK cell-mediated cytotoxicity by increasing expression of NKG2D ligands. This evidence concerns the gene KLRK1 and neoplasm.